The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...

The US Food and Drug Administration (FDA) has granted emergency use authorization for Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 formula), to be used in patients 12 years of age and older. The ...

This year’s approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 11. The latest shots from Moderna and Pfizer will now target a ...

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and ...

Novavax’s recent FDA approval for an updated COVID-19 vaccine has fueled a significant rebound in its stock price, with a ...

In Australia, our process differs slightly and tends to take a little longer. The TGA’s website indicates applications for ...

Also Read: FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax’s Shot. “Our updated vaccine targets JN.1, the ‘parent strain’ of currently circulating ...